Freshfields Bruckhaus Deringer has brought on Adam Golden to serve as head of U.S. life sciences transactions, further expanding on the London-founded firm's recent growth in the U.S. legal market.
Golden, who advises pharmaceutical, biotech and medical device companies and investors, joins as a partner in New York from Hogan Lovells, where he was head of the New York corporate practice group.
Golden's client base has included Novartis AG, Gilead Sciences Inc and Celgene Corp, including Novartis's $8.7 billion acquisition of AveXis and Celgene's $9 billion purchase of June Therapeutics and acquisition of Impact Biomedicines for up to $7 billion, the firm said. Among other new hires, the firm earlier this month added technology, data and cybersecurity attorney Brock Dahl from the U.S. National Security Agency. Joining Freshfields as counsel, Dahl sits in the firm's D.C. and Silicon Valley offices.
John Fisher, who leads Freshfields' life sciences and technology M&A practice in the U.S., highlighted that activity in the life sciences arena.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
N.Y. Gov. Andrew Cuomo's Covid book deal worth more than $5.1 millionCuomo previously refused to say how much he was being paid for the book, which is already the subject of a probe by the state Attorney General's office.
Read more »
In Post-Pandemic Workouts, You Can Exercise Too MuchMany things can cause rhabdo, including trauma, drug use, statins, severe dehydration, and extreme temperatures. And, amidst a potential post-pandemic gym rush, experts are urging gym-goers and fitness instructors to be on the lookout.
Read more »
Watch the Teaser for 'The Hot Zone: Anthrax' Starring Daniel Dae KimThe actor leads an all-new season of the National Geographic anthology series about real-life events.
Read more »
AT&T Agrees to Merge Media Business With DiscoveryThe deal would merge the telecom giant’s media assets, including CNN, into a new publicly traded company led by Discovery Chief Executive David Zaslav.
Read more »